摘要
目的探讨术后辅助化疗对交界性卵巢肿瘤预后的影响。方法对10年收治的交界性卵巢肿瘤26例的临床资料进行回顾性分析。结果23例接受术后辅助化疗,PC或PCA方案。5年、10年、15年生存率分别为100.00%、95.65%、95.65%。结论术后给予4~6个疗程的辅助化疗较为合适。腹腔内灌注疗法,能减少全身反应,更有利于控制肿瘤复发,对改善预后有好处。
Objective To investigate the effect of chemotherapy of borderline ovarian tumors (BOT) on the prognosis. Methods Retrospectively study 26 cases of BOT from 1990 to 1999. Results Chemotherapy postoperatively be given in 23 patients, the scheme of the chemotherapy are PC or PCA. The 5,10 and 15-years survival rates were 100.0 %, 95.65 % and 95.65 % respectively. Conclusion The postoperative chemotherapy with 4 to 6 courses is appropriate. Intraperitoneal chemotherapy is of value to control the recurrent and improve the prognosis of BOT.
出处
《实用癌症杂志》
2006年第1期57-58,共2页
The Practical Journal of Cancer
关键词
交界性卵巢肿瘤
辅助化疗
预后
Borderline ovarian tumors
Chemotherapy
Prognosis